Compact C-Arm Market Size & Share, by Product Type (Fixed C-Arms, Mobile C-Arms); Application; End User - Global Supply & Demand Analysis, Growth Forecasts, Statistical Report 2025-2037

Compact C-Arm Market - Regional Analysis

North America Market Insights

North America is maintaining a dominating position in the global compact C-arm market, which is projected to capture the largest market share of 39.5% by the end of 2037.  The region is pledged by the presence of rising trauma cases and Medicare expansion of ASC-eligible procedures. In this context, the CDC reports over 11.5 million yearly fracture instances, creating a sustained demand. Medicare also expanded its access, which is expected to offer coverage to 75% of fluoroscopy-guided surgeries by the end of 2030. Moreover, the regulatory shifts with the U.S. FDA’s 510(k) pathway for AI C-arms further boost adoption.

U.S. is steadily augmenting its position in the regional compact C-arm market, highly attributed to the AI-based C-arms and reimbursements offered. For instance, the National Institute of Health funded an amount of USD 485 million for low-dose imaging, whereas Medicaid offers coverage to 36% of mobile C-arms. Besides, the ASCs are escalating the demand with 43% new installations, owing to the 66% outpatient shifts, according to the AHRQ data. Furthermore, DoD contributes to this augmentation with a purchase of over 300 units annually, hence creating an optimistic market opportunity.

Canada also follows the North America compact C-arm market that is anticipated to reach CAD 426.8 million over the discussed timeframe. The market growth is highly propelled by the provincial healthcare grants, with Ontario assigning CAD 86.5 million for fabricating surgical procedures. Moreover, the Canada Institute for Health Information stated that there is a 22.5% increase in orthopedic procedures driving adoption of flat-panel detectors. Furthermore, Health Canada funded CAD 50 million to support R&D for domestic AI-based equipment.

Europe Market Insights

Europe is likely to attain its position as the second-largest shareholder in the global compact c-arm market, grabbing a share of 28.5% during the forecast tenure. The presence of a rapidly aging population, adoption of minimally invasive surgeries, and nationwide regulatory harmonization are key factors responsible for this upliftment. For instance, in 2023, EMA reported that the EU Medical Device Regulation has successfully streamlined approvals by reducing clearance duration by 32%, whereas the region’s Health Data Space initiative grants €2.6 billion for MedTech innovation, including low-dose pediatric C-Arms.

Germany is the crucial leader in Europe’s compact C-arm market, which captured a dominating share of 33.7% in the regional aspect. The market witnessed an increased annual spending surpassing €4.6 billion, which marks a key factor for progress in the country. On the other hand, the BAK 2023 article states that the flat-panel detector mandates imposed led to adoption in 92% of hospitals in the country, providing a huge opportunity for both domestic and international players to launch more of such effective equipment. The BMBF’s €310 million AI grant accelerates smart C-Arm adoption, significantly reducing radiation exposure by 40%

The U.K. is at the forefront, contributing to the worldwide upliftment of the compact C-arm market, comprising a 24.3% share in the regional market throughout the assessed timeframe. The National Health Service (NHS) granted £1.4 billion in terms of surgical tech fund, thereby focusing on penetration across 53% of ambulatory surgical centers by the end of 2030. Besides, the Association of the British Pharmaceutical Industry in 2023 reported a 26.3% CAGR in robotic knee replacements, providing a sustained demand for high-precision C-arms.

APAC Market Insights

Asia Pacific is estimated to exhibit the fastest rate of expansion in the compact C-arm market at a CAGR of 6.5% between 2025 and 2037. The accelerated upliftment is the result of an expanded geriatric population, rising procedural volumes, and government-led healthcare modernization initiatives. The trend of adopting new exclusive AI-based mobile equipment and surgical robotics is also a visible growth factor propelling revenue in this sector. Furthermore, the demand for high-precision fluoroscopy and new installations in healthcare facilities is amplifying the success of this region in the compact-C arm sector.

China is solidifying its position as a dominating player in the Asia Pacific’s compact C-arm market with a revenue share of 38.2% by the end of 2037. This is achieved by the 2.2 billion national medical imaging upgrade plan targets 5,000 tier 2 and 3 hospitals. Besides, the government implemented the 14^th Five-Year Plan as the epicenter for this growth, prioritizing AI-powered C-arms with 46% new installations featuring flat panel detectors. For instance, NHC in 2024 revealed that over 1.6 million patients leveraged C-arm guided surgeries in 2023, effectively attributed to a 16% year-over-year rise in orthopedic procedures. With the support from NMPA’s fast-track approvals, domestic manufacturers such as United Imaging grab 64% of the share in the country’s market.

India is presenting an intensifying landscape in the compact C-arm market filled with diverse revenue opportunities for domestic as well as international leaders. According to the NHA data in 2024, the market displayed USD 1.9 million annual spending on C-arms, with over 12,500 mobile units gaining funding from the Ayushman Bharat scheme.  Additionally, this became possible with a 9.6% CAGR owing to the 2.5 million procedures and a 200% booming demand for ASCs since 2020. Furthermore, domestic players in the country, such as Trivitron, emphasize 32% import-duty waivers under the Make in India initiative.

Country-wise Government Allocations